(Total Views: 100)
Posted On: 09/22/2022 9:55:49 AM
Post# of 108532

$SPRO News Article - GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr https://marketwirenews.com/news-releases/gsk-...08051.html


My Twitter: WhyteStocks